Abstract
AbstractCoronary artery disease (CAD) and aortic stenosis (AS) frequently coexist. The advent of transcatheter aortic valve implantation (TAVI) and its increased use over the last decade has brought a paradigm shift in the management of patients with severe AS who are considered inoperable or high risk for sAVR. The most appropriate management of coexistent CAD in patients undergoing TAVI is yet to be defined. In this article, we present a review of the issues arising in the management of CAD in patients with severe AS—with particular reference to those who are undergoing TAVI.Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/5222680/Activity.aspx
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
